ACM
PFE icon

ADAR1 Capital Management’s Pfizer PFE Stock Holding History

ADAR1 Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-43,000
Closed -$1.24M – 281
2023
Q4 		$1.24M Buy
+43,000
New +$1.3M 0.44% 39

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

ADAR1 Capital Management's PFE Position: Q1 2026 in Review

ADAR1 Capital Management increased its Pfizer (PFE) stake by 6.9% in Q1 2026, buying an estimated $133K and bringing the position to 77,400 shares worth $2.17M. The position accounts for 0.13% of the portfolio, ranked #119.

ADAR1 Capital Management first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.95M in Q1 2024. 2,940 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • ADAR1 Capital Management held 77,400 shares of Pfizer worth $2.17M as of Q1 2026.
  • ADAR1 Capital Management bought 5,000 Pfizer shares in Q1 2026, an estimated $133K.
  • Pfizer made up 0.13% of ADAR1 Capital Management's portfolio in Q1 2026, its #119 holding.
  • ADAR1 Capital Management first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
  • ADAR1 Capital Management's Pfizer position peaked at $2.95M in Q1 2024.
  • 2,940 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.